Main Takeaway: Stacy Tannenbaum, lead of the Pharmacometrics Group in the US for Astellas Pharma Global Development, reviews the various ... Rajesh Krishna, Senior Director with IDD Certara, reflects on how decision analysis can be used to support drug development.
Midd Training Module 1 -
Stacy Tannenbaum, lead of the Pharmacometrics Group in the US for Astellas Pharma Global Development, reviews the various ... Rajesh Krishna, Senior Director with IDD Certara, reflects on how decision analysis can be used to support drug development. Stacy Tannenbaum, the lead of the Pharmacometrics Group in the US for Astellas Pharma Global Development, discusses ...
Important details found
- Stacy Tannenbaum, lead of the Pharmacometrics Group in the US for Astellas Pharma Global Development, reviews the various ...
- Rajesh Krishna, Senior Director with IDD Certara, reflects on how decision analysis can be used to support drug development.
- Stacy Tannenbaum, the lead of the Pharmacometrics Group in the US for Astellas Pharma Global Development, discusses ...
- Director for Innovation & Partnership in the Office of Clinical Pharmacology, Office of Translational Sciences ...
- This lecture by Jeffrey Barrett from the Critical Path Institute describes the
Why this topic is useful
This topic is useful when readers need a quick overview first, then want to move into supporting details and related references.
Frequently Asked Questions
Why are related topics included?
Related topics help readers compare nearby references and understand the broader subject.
What is this page about?
This page summarizes Midd Training Module 1 and connects it with related entries, references, and supporting context.
Is the information always complete?
Not always. Some topics may need verification from official or primary sources.
